Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Patel Group have discovered a new human disease caused by formaldehyde accumulation in cells

Red and white blood cells depicted in a vessel as a digital 3D rendering with more white cells in a person with leukaemia.

Formaldehyde might be familiar to most of us as the pungent liquid used to preserve animals and organ specimens, but research from the Patel group finds that the body actually produces its own significant amount of formaldehyde too.

Now, in a paper published in Molecular Cell, the team have discovered a new human disease caused by the accumulation of this endogenous formaldehyde.  

Formaldehyde preserves biological specimens by chemically reacting with proteins and DNA crosslinking them, making them very resistant to degradation. This preserving process also destroys the ability of these proteins and DNA to function, making it highly toxic to cells. 

The Patel group has previously revealed that not only does the body produce formaldehyde as a by-product of essential metabolic processes, including the breakdown of the vitamin folate, and also found that we have enzymes that protect us from its harmful action. Formaldehyde is removed by the enzyme alcohol dehydrogenase 5 (ADH5). If some of the formaldehyde evades this first tier of defence, DNA repair enzymes can be recruited to fix any resulting DNA damage. This two-tiered defence mechanism provides effective protection against formaldehydes. However, if both these processes are removed or faulty, animals accumulate irreversible DNA damage causing multiple organs to fail and blood production to cease. 

Essential enzymes

In their most recent study, Felix Dingler and Meng Wang worked with others in the Patel team to find out whether the second tier can always make up for loss of ADH5, or if there are additional enzymes involved in formaldehyde clearance.

Aldehyde dehydrogenase 2 (ALDH2) is what's known as a tier-1 enzyme, involved in clearing the similarly toxic aldehyde species acetaldehyde, known for being a product of the metabolism of ethanol in alcoholic drinks.

They discovered that most mice lacking the enzyme aldehyde dehydrogenase 2 (ALDH2) as well as ADH5 did not survive long after birth. The few that did had stunted growth, defects in their immune systems and blood, and aged prematurely.

Collaborating with Dr Rebecca Cordell and Prof Paul Monks at Leicester University, the team measured blood formaldehyde levels and confirmed that mice lacking both ADH5 and ALDH2 enzymes accumulated a higher concentration of formaldehyde.

Despite showing evidence of increased DNA repair responses, cells from these double-deficient mice accumulated higher levels of DNA damage and mutations than controls, highlighting the importance of metabolic detoxification by tier-1 enzymes. Strikingly, as Felix Dingler, co-author of the study, says: “The mutational pattern revealed by the formaldehyde-accumulating mice shares remarkable similarity to known mutation patterns found in human cancer samples for which no cause has been identified thus far. This work raises the possibility that formaldehyde from within the body might be an important contributor to these mutations.”

Formaldehyde Mol Cell diagram


The human connection

ALDH2 deficiency is a common genetic trait in East Asia, affecting about 500 million people worldwide and is responsible for the flush reaction some people experience following alcohol consumption. To understand this human connection, the researchers collaborated with Prof Minoru Takata at the University of Kyoto, who identified several families where combined ALDH2 and ADH5 mutations were passed on from parents to children. These children are born with severe developmental defects, later developing bone marrow failure and leukaemia.

Studies on cells obtained from these patients indicated that their DNA repair processes run into overdrive. Prof Patel said “We think that these really high levels of DNA repair processes are probably because the cells from these are accumulating dangerously high levels of endogenous formaldehyde that cannot be cleared. We think that formaldehyde accumulation in humans defines a new human disease.”

 “This new research also establishes how and why most of us are protected against this very simple but highly reactive ubiquitous molecule.”

The Patel group now plan to investigate where this formaldehyde is produced in us and how it specifically damages blood production. This may lead to interventions that could reduce its mutagenic effects.


Read the full paper

Similar stories

DNA breakthrough could help identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

New clinical trial for patients affected by blood cancer

Radcliffe Department of Medicine's Professor Adam Mead is leading PROMise, a new clinical trial offering a novel treatment option for patients with a type of blood cancer called myelofibrosis.

Immune cells imperfect at distinguishing friend from foe

When it comes to distinguishing a healthy cell from an infected one that needs to be destroyed, the immune system’s killer T cells sometimes make mistakes. This discovery, described today in the journal eLife, upends a long-held belief among scientists that T cells were nearly perfect at discriminating friend from foe. The results may point to new ways to treat autoimmune diseases that cause the immune system to attack the body, or lead to improvements in cutting-edge cancer treatments.

Professor Graham Ogg elected Academy of Medical Sciences Fellow

Fellows are selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.

New funding for early diagnosis research using platelets

Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.